Journal of Cardiovascular Electrophysiology · 2002 · 64 citations · 16 references
MedicineCardiologyClinical CardiologyExercise PhysiologyExercise TestingCardiac AssessmentCardiac PacingCardiac Risk AssessmentCardiopulmonary Exercise TestingCycle Ergometer TestingExercise-induced ArrhythmiasAtrial Arrhythmias During ExerciseElectrophysiologic EffectsExercise Heart Rate MonitoringExercise-induced Ventricular ArrhythmiasHeart RateHeart Rate Response To Cycle ErgometryImplantable Cardioverter DefibrillatorsPacing
INTRODUCTION: T wave alternans (TWA) is a heart rate-dependent marker of vulnerability to ventricular arrhythmias. Atrial pacing and exercise both are used as provocative stimuli to elicit TWA. However, the prognostic value of the two testing methods has not been compared. The aim of this prospective study was to compare the prognostic value of TWA measured during bicycle exercise and atrial pacing in a large cohort of high-risk patients with ischemic heart disease and left ventricular dysfunction. METHODS AND RESULTS: This was a prospective study of 251 patients with coronary artery disease and left ventricular dysfunction who were referred for electrophysiologic studies (EPS) for standard clinical indications. Patients underwent TWA testing using bicycle ergometry (exercise TWA, n = 144) and/or atrial pacing (pacing TWA, n = 178). The primary endpoint was the combined incidence of death, sustained ventricular arrhythmias, and appropriate implantable cardioverter defibrillator therapy. The predictive value of exercise and pacing TWA for EPS results and for endpoint events was determined. Exercise and pacing TWA both were significant predictors of EPS results (odds ratios 3.0 and 2.9 respectively, P < 0.02). Kaplan-Meier survival analysis of the primary endpoint revealed that exercise TWA was a significant predictor of events (hazard ratio 2.2, P = 0.03). In contrast, pacing TWA had no prognostic value for endpoint events (hazard ratio 1.1, P = 0.8). CONCLUSION: TWA should be measured during exercise when it is used for clinical risk stratification. EPS results may not be an adequate surrogate for spontaneous events when evaluating new risk stratification tests.
16
Sudden Cardiac Death in the United States, 1989 to 1998
Zhi‐Jie Zheng, Janet B. Croft, Wayne H. Giles et al. · Circulation · 2001 · 1.6K citations · Full text